Protective effect of S-allyl cysteine sulphoxide (alliin) on glycoproteins and hematology in isoproterenol induced myocardial infarction in male Wistar rats

Journal of Applied Toxicology

Volumn 28, Issue 5, 2008, Pages 710-716

  Sangeetha, T ^a   Quine, S Darlin ^a  

^a SASTRA UNIVERSITY   (India)

Author keywords

Alliin; Glycoproteins; Hematology; Isoproterenol; Myocardial infarction

Indexed keywords

ALBUMIN; ALLIIN; CALCIUM; FIBRINOGEN; GLOBULIN; GLUCOSE; GLYCOGEN; GLYCOPROTEIN; HEMOGLOBIN; IRON; ISOPRENALINE; POTASSIUM; PROTEIN; PROTHROMBIN; SODIUM; URIC ACID;

ALBUMIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; BLOOD CLOTTING; CALCIUM BLOOD LEVEL; CARDIOTOXICITY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EOSINOPHIL; ERYTHROCYTE; ERYTHROCYTE SEDIMENTATION RATE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART PROTECTION; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; IRON BINDING CAPACITY; IRON BLOOD LEVEL; LEUKOCYTE; LYMPHOCYTE; MALE; NEUTROPHIL; NONHUMAN; PHARMACODYNAMICS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; RAT; SODIUM BLOOD LEVEL; THROMBOCYTE COUNT; URIC ACID BLOOD LEVEL;

ADRENERGIC BETA-AGONISTS; ANIMALS; BLOOD CELL COUNT; BLOOD CHEMICAL ANALYSIS; BLOOD COAGULATION; CARDIOTONIC AGENTS; CYSTEINE; GLYCOPROTEINS; ISOPROTERENOL; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, WISTAR;

RATTUS; RATTUS NORVEGICUS;

EID: 47549101410     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1330     Document Type: Article

References (45)

1. Aghi M, Husain Z, Pillai KK, Qadry JS, Balani DK, Imran M. 1992. Cardioprotective effect of cromakalim (potassium channel opener) in isoproterenol induced myocardial infarction in rats. Indian J. Exp. Biol. 30: 611-614.
2. Ahmed K, Thomas BS. 1971. The effect of long chain fatty acids on sodium potassium ion stimulated adenosine triphosphate of rat brain. J. Biol. Chem. 246: 103-109.
3. Alpert JS, Thygesen K, Antman E, Bassand JP. 2000. Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J. Am. Coll. Cardiol. 36: 959-969.
4. Ascherio A, Willet WC, Rimm EB, Giovannucci EL, Stampfer MJ. 1994. Dietary iron intake and risk of coronary disease among men. Circulation 89: 969-974.
5. Ashraf M, Samra ZQ. 1993. Subcellular distribution of xanthine oxidase during cardiac ischemia and reperfusion: an immunocytochemical study. J. Submicrosc. Cytol. Pathol. 25: 193-201.
6. 2+ binding amino acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur. J. Biochem. 268: 42-47.
7. Biemond P, Swaak AJ, Beindorff CM, Koster JF. 1986. Superoxide dependent and independent mechanisms of iron mobilization from ferritin by xanthine oxidase. Implications for oxygen free radical induced tissue destruction during ischemia and inflammation. Biochem. J. 239: 169-173.
8. Blajchman MA, Senyi AF, Hirsh J, Surya Y, Buchanan M, Mustard JF. 1979. Shortening of the bleeding time in rabbits by hydrocortisone caused by inhibition of prostacyclin generation by the vessel wall. J. Clin. Invest. 63: 1026-1035.
9. Bottiger LE, Svedberg CA. 1967. Normal erythrocyte sedimentation rate and age. Br. Med. J. 2: 85-87.
10. Burr ML, Holliday RM, Fehily AM. 1992. Hematological prognostic indices after myocardial infarction: from the Diet and Reinfarction Trial (DART). Eur. Heart J. 13: 166-170.
11. Dische L, Shettles LB. 1948. Specific colour reactions of methyl pentoses and spectrophotometric micromethod for their determination. J. Biol. Chem. 175: 595-604.
12. Dubois M, Gilles KA. 1956. Methods in Enzymology. Academic Press: New York; 83.
13. Ernst E, Weihmayr T, Schmid M, Baumann M, Matrai A. 1986. Cardiovascular risk factors and hemorheology. Physical fitness, stress and obesity. Atherosclerosis 59: 263-269.
14. Friedman GD, Tekawa I, Grimm RH, Manolio T, Shannon SG, Sidney S. 1990. The leucocyte count: correlates and relationship to coronary risk factors: the CARDIA study. Int. J. Epidemiol. 19: 889-893.
15. Gokmen SS, Kilicli G, Ozcelik F, Gulen S. 2000. Serum total and lipid bound sialic acid levels following acute myocardial infarction. Clin. Chem. Lab. Med. 38: 1249-1255.
16. Hansson GK, Holm J, Holm S, Fotev Z, Hedrich HJ, Fingerle J. 1991. T-Lymphocytes inhibit the vascular response to injury. Proc. Natl Acad. Sci. 88: 10530-10534.
17. Jan KC, Shu EC. 2005. Antioxidants and myocardial ischemia: Reperfusion injuries. Chang. Gung. Med. J. 28: 369-376.
18. Jennings RB, Reimer KA, Steenbergen C. 1986. The osmolar load, membrane damage and reperfusion. J. Mol. Cell. Cardiol. 18: 769-780.
19. Knufman NM, Van Der Laarse A, Vliegen HW, Brinkman CJ. 1987. Quantification of myocardial necrosis and cardiac hypertrophy in isoproterenol treated rats. Res. Commun. Chem. Pathol. Pharmacol. 57: 15-32.
20. Kristensen SD, Milner PC, Martin JF. 1988. Bleeding time and platelet volume in acute myocardial infarction a two year follow up study. Thromb. Haemost. 59: 353-356.
21. Lachmann G, Lorenz D, Radeck W, Steiper M. 1994. The pharmaco-kinetics of S35 labelled garlic constituents alliin, allicin and vinyldithiine. Arzneimittelforsch. 744: 734-743.
22. Lempert H. 1967. Tyrosine method of plasma protein determination. In Practical Clinical Biochemistry, Varley H (ed.). William Heinemann Medical Books Ltd: London and Interscience Books Inc: New York; 245.
23. 2+] studies in isolated rat cardiomyocytes. J. Physiol. 496: 111-128.
24. Lowry OH, Rosebrough MJ, Farr AL, Randall RJ. 1951. Protein measurement with Folin-phenol reagent. J. Biol. Chem. 193: 265-275.
25. Masuda H, Wakabayashi R, Wakabayashi I. 1998. Serum sialic acid and ankle versus brachial arterial pressure ratio in NIDDM. Scand. J. Clin. Lab. Invest. 58: 433-439.
26. Meade TW, North WR, Chakrabarti R, Stirling Y, Haines AP, Thompson SG, Brozovie M. 1980. Hemostatic function and cardiovascular death: early results of a prospective study. Lancet 1: 1050-1054.
27. Monkhouse FC, Mactnillan RL. 1966. The coagulation (clotting) of blood. In The Physiological Basis of Medical Practice, Best CR, Taylor NB (eds). The Williams and Wilkins Co: Baltimore; 588-593.
28. Morales MA, Jabbagy AJ, Terenizi HF. 1973. Mutations affecting accumulation of glycogen. Neurospora News Lett. 20: 24-25.
29. Mukesh N, Ojhal SK, Ranjit K. 2005. Changes in levels of serum glycoproteins in major depressive disorders. Indian J. Clin. Biochem. 20: 154-157.
30. Ommen SR, Hodge DO, Rodeheffer RJ, McGregor CGA, Thomson SP, Gibbons RJ. 1998. Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation 97: 19-22.
31. Prabhu S, Jainu M, Sabith EK, Shyamala Devi CS. 2005. A study on the beneficial effect of mangiferin on isoproterenol induced myocardial infarction rat model. Pharmacogn. Mag. 1: 92-96.
32. Rajadurai M, Stanely Mainzen Prince P. 2007. Preventive effect of naringin on isoproterenol induced cardiotoxicity in Wistar rats: an in vivo and in vitro study. Toxicology 232: 216-225.
33. Ramsay WNM. 1969a. Plasma iron. In Advances in Clinical Chemistry, Sobotka H, Steward P (eds). Academic Press: New York; 1-3.
34. Ramsay WNM. 1969b. Ramsay's dipyridyl method for iron binding capacity. In Practical Clinical Chemistry, Varley H (ed.). Heinemann: London; 475-476.
35. Rankinen T, Hietanen E, Vaisanen S, Lehtio M, Penttila I, Bouchard C, Rauramaa R. 2000. Relationship between lipid peroxidation and plasma fibrinogen in middle aged men. Thromb. Res. 5: 453-459.
36. Salman H, Bergman M, Bessler H, Punsky I, Djaldetti M. 1999. Effect of garlic derivatives on peripheral blood cell immune response. Int. J. Immunopharmacol. 21: 589-597.
37. Sangeetha T, Darlin Quine S. 2006a. Preventive effect of S-allyl cysteine sulfoxide (alliin) on cardiac marker enzymes and lipids in isoproterenol induced myocardial injury. J. Pharm. Pharmacol. 58: 617-623.
38. Sangeetha T, Darlin Quine S. 2006b. Antilipoperoxidative and anti-oxidant effects of S-allyl cysteine sulfoxide on isoproterenol-induced myocardial infarction in Wistar rats. J. Biochem. Mol. Toxicol. 20: 167-173.
39. Sangeetha T, Darlin Quine S. 2007. Preventive effect of S-allyl cysteine sulfoxide (alliin) on lysosomal hydrolases and membrane bound ATPases in isoproterenol-induced myocardial infarction in Wistar rats. J. Biochem. Mol. Toxicol. 21: 118-124.
40. Sathish V, Ebenezer KK, Devaki T. 2003. Biochemical changes on nicorandil and amlopdipine during experimental myocardial infarction in rats. Pharmacol. Res. 48: 565-570.
41. Sewel R, Ibbotson RM, Phillips R, Carson P. 1984. High mean platelet volume after myocardial infarction: is it due to consumption of small platelets. Br. Med. J. 289: 1576-1578.
42. Sheela CG, Augusti KTV. 1992. Antidiabetic effects of S-allyl cysteine sulphoxide isolated from garlic Allium sativum Linn. Indian J. Exp. Biol. 30: 523-526.
43. 2+ channel function and drug action. Trends Pharmacol. Sci. 16: 43-49.
44. Wagner WD. 1979. A more sensitive assay discriminating galactosamine and glucosamine in mixtures. Anal. Biochem. 94: 394-396.
45. Warren L. 1959. The thiobarbituric acid assay of sialic acids. J. Biol. Chem. 234: 1971-1975.